We exist to improve the quality of human life by enabling people to do more, feel better, live longer.
As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization's three priority diseases HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields.
Our product portfolio also includes a range of consumer brands, many of which are household names around the world: Lucozade, Sensodyne, Aquafresh, Ribena, Horlicks, Panadol, Tums.
... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with GlaxoSmithKline plc.?
LONDON, July 21, 2017 /PRNewswire/ -- GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult [...]
PHILADELPHIA, July 14, 2017 /PRNewswire/ -- GSK (LSE/NYSE: GSK) today announced it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release approval from [...]
ROCKVILLE, Md., May 1, 2017 /PRNewswire/ -- GSK today announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for [...]